C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations

C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理

基本信息

  • 批准号:
    10668488
  • 负责人:
  • 金额:
    $ 39.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-01 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

C-DIAS RESEARCH PROJECT 2: PROJECT SUMMARY/ABSTRACT This rigorous experiment addresses a critical public health problem--the rising stimulant/opioid epidemic. It advances implementation science through the evaluation of a multi-level implementation strategy and specifies of contextual determinants of outcomes. Stimulants constitute a new and deadly fourth wave of the opioid epidemic. Among persons with opioid use disorder, stimulant use has been associated with more persistent opioid use; higher risk of HIV infection; higher levels of family, medical, legal, and vocational problems; and higher risk of lethal overdose. Contingency management (CM) is the most effective intervention for stimulant use and is an evidence-based adjunct to medication for opioid use disorder (MOUD). Yet, uptake of CM in opioid treatment programs (OTPs) that provide MOUD remains low: in fact, access to CM is arguably one of the greatest research-to-practice gaps in the addiction treatment services field. The goal of C-DIAS Research Project 2 is to conduct a type III hybrid effectiveness-implementation trial to evaluate a multi-level implementation strategy, the Science to Service Laboratory (SSL), to install CM for stimulant use in OTPs. The SSL has three core components: didactic training; performance feedback; and external facilitation. The project employs common C-DIAS frameworks, measures, and methods to guide SSL evaluation. Utilizing a stepped wedge design, a regional cohort of 10 public sector OTPs will be randomized to receive SSL at five distinct time points. At six intervals, each of the 10 OTPs will provide data from all available patient charts on CM delivery and patient outcomes. Each OTP will also recruit 10 patients per wedge (n = 500 patients) to complete a baseline interview and 3-month follow-up. In addition, staff from each OTP will report on contextual determinants of implementation outcomes at three timepoints. This study will rigorously evaluate whether a multi-level implementation strategy developed by one of the longest-standing national intermediary purveyor organizations--the SAMHSA Technology Transfer Centers, will improve both implementation and patient outcomes. Implementation outcomes are guided by RE-AIM and include CM Reach, Adoption, Implementation and Sustainment, while patient outcomes include measures of CM Effectiveness such as stimulant abstinence and treatment retention. The study will advance the C-DIAS scientific aims by unpacking the black box of implementation strategies and exploring the mediational and moderating influence of context on implementation outcomes. Focused on the active IMPLEMENT phase, this Research Project leverages a bi- directional synergistic relationship with C-DIAS. Some but not all examples of this include: 1) standardized measures of implementation context, outcomes and procedural details of strategies; 2) PI (Becker)’s role on the C-DIAS Research Core; 3) a close network of collaboration and mentoring among the key project personnel and C-DIAS PI; and 4) harmonization of data that can be used for modeling by C-DIAS Research Core experts.
C-dias研究项目2:项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sara J. Becker其他文献

Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
2006-2015 年镰状细胞病 ED 患者阿片类药物使用性别差异的评估。
Randomized Clinical Trials in Behavioral Medicine
行为医学随机临床试验
Interventions for Substance Use Disorders in Adolescents: A Systematic Review
青少年药物使用障碍的干预措施:系统评价
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    D. Steele;Sara J. Becker;Kristin J. Danko;E. Balk;I. Saldanha;G. Adam;S. Bagley;C. Friedman;A. Spirito;Kelli Scott;E. Ntzani;Imani Saeed;Bryant T. Smith;J. Popp;T. Trikalinos
  • 通讯作者:
    T. Trikalinos
Proceedings of the 13th annual conference of INEBRIA
  • DOI:
    10.1186/s13722-016-0062-9
  • 发表时间:
    2016-09-01
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Rod Watson;James Morris;John Isitt;Pablo Barrio;Lluisa Ortega;Antoni Gual;Kenneth Conner;Tracy Stecker;Stephen Maisto;Sophie Paroz;Caroline Graap;Véronique S Grazioli;Jean-Bernard Daeppen;Susan E Collins;Nicolas Bertholet;Jennifer McNeely;Vlad Kushnir;John A. Cunningham;Iain K Crombie;Kathryn B Cunningham;Linda Irvine;Brian Williams;Falko F Sniehotta;John Norrie;Ambrose Melson;Claire Jones;Andrew Briggs;Peter Rice;Marcus Achison;Andrew McKenzie;Elena Dimova;Peter W Slane;Véronique S. Grazioli;Susan E. Collins;Sophie Paroz;Caroline Graap;Jean-Bernard Daeppen;Stéphanie Baggio;Marc Dupuis;Joseph Studer;Gerhard Gmel;Molly Magill;Véronique S. Grazioli;Robert J. Tait;Lucinda Teoh;Erin Kelty;Elizabeth Geelhoed;David Mountain;Gary K. Hulse;Elina Renko;Shannon G. Mitchell;David Lounsbury;Zhi Li;Robert P. Schwartz;Jan Gryczynski;Arethusa S. Kirk;Marla Oros;Colleen Hosler;Kristi Dusek;Barry S. Brown;Deborah S. Finnell;Aisha Holloway;Li-Tzy Wu;Geetha Subramaniam;Gaurav Sharma;Sara Wallhed Finn;Sven Andreasson;Robert D. Dvorak;Matthew P. Kramer;Brittany L. Stevenson;Emily M. Sargent;Tess M. Kilwein;Sion K. Harris;Lon Sherritt;Sarah Copelas;John R. Knight;Noreen D Mdege;Jim McCambridge;Gallus Bischof;Anja Bischof;Jennis Freyer-Adam;Hans-Juergen Rumpf;Niamh Fitzgerald;Lisa Schölin;Paul Toner;Jan R. Böhnke;Laura J. Veach;Olivia Currin;Leigh Z. Dongre;Preston R. Miller;Elizabeth White;Emily C. Williams;Gwen T. Lapham;Jennifer J. Bobb;Anna D. Rubinsky;Sheryl L. Catz;Susan Shortreed;Kara M. Bensley;Katharine A. Bradley;Joanna Milward;Paolo Deluca;Zarnie Khadjesari;Rod Watson;Stephanie Fincham-Campbell;Colin Drummond;Kathryn Angus;Linda Bauld;Sophie Baumann;Katja Haberecht;Inga Schnuerer;Christian Meyer;Hans-Jürgen Rumpf;Ulrich John;Beate Gaertner;Marion Barrault-Couchouron;Marion Béracochéa;Vincent Allafort;Valérie Barthélémy;Hervé Bonnefoi;Emmanuel Bussières;Véronique Garguil;Marc Auriacombe;Marianne Saint-Jacques;Michel Dorval;Katia M’Bailara;Lidia Segura-Garcia;Nuria Ibañez-Martinez;Juan Manuel Mendive-Arbeloa;Manel Anoro-Perminger;Pako Diaz-Gallego;Mª Angeles Piñar-Mateos;Joan Colom-Farran;Marianthi Deligianni;Bertrand Yersin;Angeline Adam;Constance Weisner;Felicia Chi;Wendy Lu;Stacy Sterling;Kevin L. Kraemer;Kathleen A. McGinnis;David A. Fiellin;Melissa Skanderson;Adam J. Gordon;Jonathan Robbins;Susan Zickmund;P. Todd Korthuis;E. Jennifer Edelman;Nathan B. Hansen;Christopher J. Cutter;James Dziura;Lynn E. Fiellin;Patrick G. O’Connor;Stephen A. Maisto;Roger Bedimo;Cynthia Gilbert;Vincent C. Marconi;David Rimland;Maria Rodriguez-Barradas;Michael Simberkoff;Amy C. Justice;Kendall J. Bryant;Anne H Berman;Gillian W Shorter;Jeremy W Bray;Carolina Barbosa;Magnus Johansson;Reid Hester;William Campbell;Maria Lucia O. Souza Formigoni;André Luzi Monezi Andrade;Laisa Marcorela Andreoli Sartes;Christopher Sundström;Niels Eék;Martin Kraepelien;Viktor Kaldo;Claudia Fahlke;Lynn Hernandez;Sara J. Becker;Richard N. Jones;Hannah R. Graves;Anthony Spirito;Silke Diestelkamp;Lutz Wartberg;Nicolas Arnaud;Rainer Thomasius;Jacques Gaume;Véronique Grazioli;Cristiana Fortini;Zelra Malan;Bob Mash;Katherine Everett-Murphy;Véronique S. Grazioli;Joseph Studer;M. Mohler-Kuo;Nicolas Bertholet;Gerhard Gmel;Lawrence Doi;Helen Cheyne;Ruth Jepson;Vanesa Luna;Leticia Echeverria;Silvia Morales;Teresa Barroso;Ângela Abreu;Cosma Aguiar;Duncan Stewart;Angela Abreu;Riany M. Brites;Rafael Jomar;Gerson Marinho;Pedro Parreira;J. Paul Seale;J. Aaron Johnson;Dena Henry;Sharon Chalmers;Freida Payne;Linda Tuck;Akula Morris;Cátia Gonçalves;Bettina Besser;Cristina Casajuana;Hugo López-Pelayo;María Mercedes Balcells;Lídia Teixidó;Laia Miquel;Joan Colom;Kimberly A. Hepner;Katherine. J. Hoggatt;Andy Bogart;Susan. M. Paddock;Sarah L Hardoon;Irene Petersen;Fiona L Hamilton;Irwin Nazareth;Ian R. White;Louise Marston;Paul Wallace;Christine Godfrey;Elizabeth Murray;Hana Sovinová;Ladislav Csémy
  • 通讯作者:
    Ladislav Csémy
“Sounds like CSI:” How consumers of adolescent substance use disorder treatment perceive the term “evidence-based practice”
“听起来像犯罪现场调查:”青少年物质使用障碍的消费者如何看待“循证实践”一词的治疗

Sara J. Becker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sara J. Becker', 18)}}的其他基金

HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
  • 批准号:
    10596437
  • 财政年份:
    2022
  • 资助金额:
    $ 39.55万
  • 项目类别:
HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
  • 批准号:
    10708983
  • 财政年份:
    2022
  • 资助金额:
    $ 39.55万
  • 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
  • 批准号:
    10665470
  • 财政年份:
    2022
  • 资助金额:
    $ 39.55万
  • 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
  • 批准号:
    10493960
  • 财政年份:
    2022
  • 资助金额:
    $ 39.55万
  • 项目类别:
Improving Outcomes of Adolescents in Residential Substance use Treatment via a Technology-Assisted Parenting Intervention
通过技术辅助育儿干预改善青少年住宅药物滥用治疗的结果
  • 批准号:
    10666175
  • 财政年份:
    2021
  • 资助金额:
    $ 39.55万
  • 项目类别:
Neighborhood perceptions and response to a technology-assisted parenting intervention for youth substance use
社区对针对青少年药物滥用的技术辅助育儿干预的看法和反应
  • 批准号:
    10836689
  • 财政年份:
    2021
  • 资助金额:
    $ 39.55万
  • 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
  • 批准号:
    10400426
  • 财政年份:
    2018
  • 资助金额:
    $ 39.55万
  • 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
  • 批准号:
    10215461
  • 财政年份:
    2018
  • 资助金额:
    $ 39.55万
  • 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
  • 批准号:
    9034960
  • 财政年份:
    2016
  • 资助金额:
    $ 39.55万
  • 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
  • 批准号:
    9263967
  • 财政年份:
    2016
  • 资助金额:
    $ 39.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了